Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Janux Therapeutics Inc (JANX)
NASDAQ:JANX
RESEARCH TOOLSreports
Janux Therapeutics Inc (JANX) Ownership Overview
55.01% Insiders
16.40% Mutual Funds
<0.01% Other Institutional Investors
7.83% ETFs
20.76% Public Companies and Individual Investors
The ownership structure of Janux Therapeutics Inc (JANX) stock is a mix of institutional, retail, and individual investors. Approximately 24.24% of the company’s stock is owned by Institutional Investors, 55.01% is owned by Insiders, and 20.76% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Oct 24, 2024 | Jay Lichter >10% Owner | xxxxxxxxxxxxx | $178084 |
| Oct 22, 2024 | Ra Capital Management, Llc Director, >10% Owner | xxxxxxxxxxxxx | $53700000 |
| Oct 18, 2024 | Avalon Ventures Xi, L.p. >10% Owner | xxxxxxxxxxxxx | $77472371 |
| Sep 30, 2024 | Avalon Ventures Xi, L.p. >10% Owner | xxxxxxxxxxxxx | $14452394 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2024 | xxxxxxxxxxxxx | $654526 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $2569920 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $2804371 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $27607686 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 10,365,652 | Insider | 17.93% | 376,998,763 | |
| 9,165,652 | Institution | 15.86% | 333,354,763 | |
| 7,377,765 | Insider | 12.76% | 268,329,313 | |
| 6,560,816 | Insider | 11.35% | 238,616,878 | |
| 4,148,680 | Insider | 7.18% | 150,887,492 | |
| 2,644,622 | Insider | 4.80% | 96,184,902 | |
| 1,993,482 | Institution | 3.45% | 72,502,940 | |
| 1,990,540 | Institution | 3.44% | 72,395,940 | |
| 1,635,816 | Institution | 2.83% | 59,494,628 | |
| 1,600,263 | Institution | 2.77% | 58,201,565 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,993,482 | Institution | 3.45% | 72,502,940 | |
| 1,408,169 | Institution | 2.44% | 51,215,107 | |
| 1,057,946 | Institution | 1.83% | 38,477,496 | |
| 1,020,589 | Institution | 1.77% | 37,118,822 | |
| 821,085 | Institution | 1.42% | 29,862,861 | |
| 790,125 | Institution | 1.37% | 28,736,846 | |
| 445,088 | Institution | 0.77% | 16,187,851 | |
| 358,160 | Institution | 0.62% | 13,026,279 | |
| 306,647 | Institution | 0.53% | 11,152,751 | |
| 285,558 | Institution | 0.49% | 10,385,744 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,181,944 | Institution | 2.04% | 63,281,282 | |
| 758,443 | Institution | 1.31% | 27,584,572 | |
| 558,532 | Institution | 0.97% | 20,760,634 | |
| 492,038 | Institution | 0.85% | 26,343,715 | |
| 293,982 | Institution | 0.51% | 10,692,125 | |
| 252,013 | Institution | 0.44% | 9,165,713 | |
| 155,668 | Institution | 0.27% | 5,786,180 | |
| 132,960 | Institution | 0.23% | 7,118,678 | |
| 131,032 | Institution | 0.23% | 7,015,453 | |
| 82,990 | Institution | 0.14% | 3,084,738 |
FAQ
Who Owns Janux Therapeutics Inc (JANX)?
According to the latest TipRanks data, approximately <0.01% of the company's stock is held by institutional investors, 55.01% is held by insiders, and 20.76% is held by retail investors.
What percentage of Janux Therapeutics Inc (JANX) stock is held by institutional investors?
According to the latest TipRanks data, approximately <0.01% of Janux Therapeutics Inc (JANX) stock is held by institutional investors.
What percentage of Janux Therapeutics Inc (JANX) stock is held by retail investors?
According to the latest TipRanks data, approximately 20.76% of Janux Therapeutics Inc (JANX) stock is held by retail investors.
Who owns the most shares of Janux Therapeutics Inc (JANX)?
Ra Capital Management, Llc owns the most shares of Janux Therapeutics Inc (JANX).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.